FDA Approves First Drug for Classic Congenital Adrenal Hyperplasia in 70 Years
(MedPage Today) -- The FDA approved crinecerfont (Crenessity) as a first-in-class treatment for classic congenital adrenal hyperplasia (CAH), the agency announced late Friday.
Crinecerfont was approved for use in combination with glucocorticoids...
Crinecerfont was approved for use in combination with glucocorticoids...